We are live on ! Find out more
WVE icon

Wave Life Sciences

81 hedge funds and large institutions have $263M invested in Wave Life Sciences in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

152% more call options, than puts

Call options by funds: $189K | Put options by funds: $75K

53% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 17

13% more funds holding

Funds holding: 7281 (+9)

11% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 19

1.96% more ownership

Funds ownership: 71.4%73.36% (+2%)

13% less capital invested

Capital invested by funds: $303M → $263M (-$40.8M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
81
Holders Change
+9
Holders Change %
+12.5%
% of All Funds
1.27%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
26
Increased
21
Reduced
19
Closed
17
Calls
$189K
Puts
$75K
Net Calls
+$114K
Net Calls Change
-$185K
Name Holding Trade Value Shares
Change
Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$62.6M
MCM
2
M28 Capital Management
Connecticut
$25.7M +$404K +100,000 +1%
MC
3
Maverick Capital
Texas
$24M
6CM
4
683 Capital Management
New York
$22M +$125K +31,000 +0.5%
BlackRock
5
BlackRock
New York
$16.8M +$13M +3,213,732 +228%
Adage Capital Partners
6
Adage Capital Partners
Massachusetts
$16.8M
BG
7
Bellevue Group
Switzerland
$16.4M
KCM
8
Kynam Capital Management
New Jersey
$14.3M +$471K +116,726 +3%
Primecap Management
9
Primecap Management
California
$13.9M -$1.49M -369,700 -9%
AG
10
Artal Group
Luxembourg
$10.4M -$523K -129,477 -4%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$4.84M +$2.57M +636,873 +92%
State Street
12
State Street
Massachusetts
$4.31M +$3.77M +933,688 +373%
Vanguard Group
13
Vanguard Group
Pennsylvania
$4.2M +$950K +235,091 +26%
LCM
14
Laurion Capital Management
New York
$3.02M -$172K -42,662 -5%
Fidelity Investments
15
Fidelity Investments
Massachusetts
$2.82M -$1.06M -261,248 -25%
Millennium Management
16
Millennium Management
New York
$2.77M -$2.69M -667,102 -47%
Northern Trust
17
Northern Trust
Illinois
$1.84M +$1.54M +382,153 +308%
NM
18
Newtyn Management
New York
$1.82M -$56.7K -14,028 -3%
JP Morgan Chase
19
JP Morgan Chase
New York
$1.73M +$148K +36,736 +8%
PIM
20
Platinum Investment Management
Australia
$1.66M
Wellington Management Group
21
Wellington Management Group
Massachusetts
$925K +$36.6K +9,057 +4%
Marshall Wace
22
Marshall Wace
United Kingdom
$816K -$587K -145,334 -39%
N
23
Nuveen
North Carolina
$751K +$833K +206,259 New
WM
24
WS Management
Florida
$702K
Bank of New York Mellon
25
Bank of New York Mellon
New York
$641K +$607K +150,179 +578%

WVE Hedge Fund Activity: Q2 2023 in Review

81 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q2 2023, worth a combined $263M — down 13% from $303M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new WVE positions and 17 closed out — a net gain of 9 holders — while 21 added to existing stakes and 19 trimmed.

The largest buyer was BlackRock, adding an estimated $13M. The largest seller was Susquehanna International Group, cutting an estimated $2.87M.

  • 81 institutional investors held Wave Life Sciences (WVE) as of Q2 2023, up from 72 in Q1 2023.
  • Funds reported $263M of Wave Life Sciences stock for Q2 2023, down 13% quarter-over-quarter.
  • 26 funds opened new Wave Life Sciences positions in Q2 2023 and 17 closed out, a net change of +9 holders.
  • The largest Wave Life Sciences buyer in Q2 2023 was BlackRock, an estimated $13M added.
  • The largest Wave Life Sciences seller in Q2 2023 was Susquehanna International Group, an estimated $2.87M sold.

Based on aggregated 13F filings for Q2 2023.